Bioenergy, Inc. Positions Itself for Growth With New Patents and Additions to Management Staff.Business Editors MINNEAPOLIS--(BUSINESS WIRE)--Jan. 31, 2001 Bioenergy, Inc. announces that the U.S. Patent Office has issued two patents covering the ability of Bioenergy Ribose(TM) to boost energy during and after exercise as well as during recovery from illness, and to prevent muscular soreness and cramping cramping see cramp. in both athletic and medical situations. Both patents have domestic and international applications. Ribose is a simple, 5-carbon monosaccharide monosaccharide: see carbohydrate. monosaccharide Any of the simple sugars that serve as building blocks for carbohydrates. They are classified based on their backbone of carbon (C) atoms: Trioses have three carbon atoms, tetroses four, pentoses , or pentose pentose /pen·tose/ (pen´tos) a monosaccharide containing five carbon atoms in a molecule. pen·tose n. sugar, used to stimulate natural energy production when added to the diet. Large amounts of ATP ATP: see adenosine triphosphate. ATP in full adenosine triphosphate Organic compound, substrate in many enzyme-catalyzed reactions (see catalysis) in the cells of animals, plants, and microorganisms. , the body's primary energy-carrying molecule, can be lost from heart and skeletal muscle cells during exercise or periods of restricted circulation affecting tissue function. Produced by the body as a building block of ATP, ribose allows the body to quickly replenish lost ATP energy stores. Studies show that ribose can increase both de novo [Latin, Anew.] A second time; afresh. A trial or a hearing that is ordered by an appellate court that has reviewed the record of a hearing in a lower court and sent the matter back to the original court for a new trial, as if it had not been previously heard nor decided. (new) synthesis and salvage rates of energy molecules. Supplemental ribose, taken in recommended amounts before, during and after exercise, will help maintain high ATP energy levels. U.S. Patent No. 6,159,942, issued Dec. 12, 2000, covers Bioenergy Ribose as a method for increasing energy levels in people during exercise or during recovery from illnesses such as infection, trauma or burn. When taken at the appropriate time and in the proper amounts, Bioenergy Ribose helps provide the needed fuel for working cells by increasing the rate at which stressed cells replace ATP. The second patent, U.S. Patent No. 6,159,943, also issued Dec. 12, protects the use of Bioenergy Ribose as a method of preventing cramping and soreness in skeletal muscles Skeletal muscles Muscles that move the skeleton. All of the muscles under voluntary control are skeletal muscles. Mentioned in: Creatine Kinase Test of mammals. Bioenergy Ribose, taken in proper amounts and at the appropriate time, provides the fuel that muscles need to do work and helps replenish ATP levels quicker, thereby eliminating the cramping and soreness associated with exercise-induced muscle pain. "These patents represent a milestone in Bioenergy's research," says Clarence Johnson Clarence Leonard "Kelly" Johnson (February 27, 1910 – December 21, 1990) was an aircraft engineer and aeronautical innovator. As a member and first team leader of the Lockheed Skunk Works, Johnson worked for more than four decades and is said to have been an 'organizing , CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Bioenergy, Inc. "They help solidify Bioenergy Ribose as a key nutritional supplement for products in the sports and fitness marketplace and provide valuable protection for medical nutritional applications. By using a supplement that contains the proper amount of Bioenergy Ribose, athletes and patients alike will be able to increase energy and improve performance while decreasing the adverse side effects Side effects Effects of a proposed project on other parts of the firm. of muscle cramping and soreness that result from strenuous exercise or recovery. As our research continues, we anticipate additional breakthroughs in ribose technology." Two New Executives Named Bioenergy, Inc. also has added two executives to its management staff. Terry Stewart joins the company as Vice President and Chief Financial Officer and will lead all the corporate finance and development for Bioenergy. He has more than 25 years of experience in corporate development and corporate finance. Stewart most recently worked for Delphi Financial, a Minneapolis investment banking firm, focusing on equity placements for private and public companies. Lou Vazquez becomes Bioenergy's Director of New Business Development. He brings 25 years of experience in the nutritional supplement industry with a focus on strategic planning Strategic planning is an organization's process of defining its strategy, or direction, and making decisions on allocating its resources to pursue this strategy, including its capital and people. , product and business development, technical and applications support, regulatory compliance and quality assurance. He formerly worked for Natural Balance, Inc., a privately held dietary supplement company based in Castle Rock, Colo. Vazquez served as vice president of technical affairs and director of new product development. Bioenergy, Inc. is a privately held company privately held company A firm whose shares are held within a relatively small circle of owners and are not traded publicly. engaged in the research, manufacture and global commercialization of ribose-based technologies. The company holds 16 issued or pending patents on ribose applications. Founded by Dr. John Foker, a cardiovascular surgeon and ribose-research pioneer, the Minneapolis-based company is committed to advancing the use of ribose to improve cardiovascular function, muscle energy recovery and athletic performance. Bioenergy manufactures ribose-based products for the medical nutrition and pharmaceutical industries, and markets Bioenergy Ribose to the nutritional-supplement and food industries. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion